2023 Full-year results

Group performance summary Year ended 30 June ($m)1 2023 2022 Var % Revenue 43,550 36,838 18.2 Revenue (excluding Wesfarmers Health) 38,238 35,598 7.4 EBIT 3,863 3,633 6.3 EBIT (after interest on lease liabilities) 3,644 3,416 6.7 NPAT 2,465 2,352 4.8 Basic earnings per share (cps) Return on equity (R12,%) Operating cash flows 217.8 207.8 4.8 31.4 29.4 2.0 ppt 4,179 2,301 81.6 Net capital expenditure 1,183 884 33.8 Free cash flows 3,627 1,110 226.8 Cash realisation ratio (%) 100 59 41 ppt Full-year ordinary dividend (fully-franked, cps) 191 180 6.1 Net financial debt 3,984 4,296 (7.3) Debt to EBITDA (x) 1.9 2.2 (0.3x) 1. Refer to slide 64 for relevant definitions. 2023 Full-year results | 9

View entire presentation